NCT00073203View on ClinicalTrials.gov

A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

488

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2004

Conditions

Major Depressive Disorder

Interventions

DRUG

R228060

DRUG

Placebo and Paroxetine

Trial Locations (1)

08560

JJ PRD Research Center, Titusville

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY